NEC的人工智能(AI)帮助医生确定结直肠病灶有无癌变

2021-07-15 国际文传 网络

NEC Corporation (NEC; TOKYO: 6701)今天宣布一项人工智能技术取得进展,该技术可帮助医生确定结直肠病灶是否属于癌变。NEC开发了一项名为“Cx20&

NEC Corporation (NEC; TOKYO: 6701)今天宣布一项人工智能技术取得进展,该技术可帮助医生确定结直肠病灶是否属于癌变。NEC开发了一项名为“Cx20”的新技术,同时寻求早期检出结直肠病灶的辅助手段。Cx20已达到欧洲安全、健康和环保标准CE标志的要求,并将整合到医疗器械AI诊断支持软件“WISE VISION® Endoscopy”(*1)中,预计将于今年下半年开始在欧洲销售。

该软件可与现有内镜设备连接并相互作用,并根据内镜检查过程中捕获的图像自动通知用户病灶有无癌变可能。其次,该软件可作为一种额外的工具,快速用于辅助内镜医师鉴别病灶并减轻患者负担。

结直肠癌起源于癌前病灶(结直肠癌性息肉),通过在内镜检查过程中检出和摘除早期病灶,有可能抑制其进展。然而,内镜医师在内镜检查时有时难以通过视检鉴别病灶有无癌变,导致不必要的活检和非癌变病灶的摘除,从而给患者造成更多压力和不适。结直肠癌据说是欧洲地区第二大癌症(*2),而在欧洲率先上市的最新版WISE VISION® Endoscopy有望帮助医生解决这一挑战性问题。

为了提高识别结直肠病灶有无癌变可能的机率,并由此帮助内镜医师做出决策,NEC开发了一项新技术,利用AI学习能力整合内镜图像信息与专科医生发现的数据。具体而言,该技术会分析内镜器械拍摄的病灶静止图像,如果AI确定某个结直肠病灶可能属于癌变,则会显示“可能性大”的通知消息。

Cx20功能支持病变识别:在检查过程中,通过内镜器械拍摄的<a href='https://edu.medsci.cn'>视频</a>自动检测疑似病灶。然后医生提取静止图像(左),快速分析并显示结果(右)(图示:美国商业资讯)

Cx20功能支持病变识别:在检查过程中,通过内镜器械拍摄的视频自动检测疑似病灶。然后医生提取静止图像(左),快速分析并显示结果(右)(图示:美国商业资讯)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044195, encodeId=c43b20441955f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Apr 21 18:10:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007484, encodeId=bf4d100e4844e, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3125569782, createdName=mingying, createdTime=Fri Aug 13 07:20:16 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453547, encodeId=10da145354e87, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557094, encodeId=a4f5155e09494, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000184, encodeId=d7361000184e7, content=谢谢 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Fri Jul 16 22:01:25 CST 2021, time=2021-07-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2044195, encodeId=c43b20441955f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Apr 21 18:10:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007484, encodeId=bf4d100e4844e, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3125569782, createdName=mingying, createdTime=Fri Aug 13 07:20:16 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453547, encodeId=10da145354e87, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557094, encodeId=a4f5155e09494, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000184, encodeId=d7361000184e7, content=谢谢 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Fri Jul 16 22:01:25 CST 2021, time=2021-07-16, status=1, ipAttribution=)]
    2021-08-13 mingying

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2044195, encodeId=c43b20441955f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Apr 21 18:10:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007484, encodeId=bf4d100e4844e, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3125569782, createdName=mingying, createdTime=Fri Aug 13 07:20:16 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453547, encodeId=10da145354e87, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557094, encodeId=a4f5155e09494, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000184, encodeId=d7361000184e7, content=谢谢 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Fri Jul 16 22:01:25 CST 2021, time=2021-07-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2044195, encodeId=c43b20441955f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Apr 21 18:10:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007484, encodeId=bf4d100e4844e, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3125569782, createdName=mingying, createdTime=Fri Aug 13 07:20:16 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453547, encodeId=10da145354e87, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557094, encodeId=a4f5155e09494, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000184, encodeId=d7361000184e7, content=谢谢 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Fri Jul 16 22:01:25 CST 2021, time=2021-07-16, status=1, ipAttribution=)]
    2021-07-17 axin014
  5. [GetPortalCommentsPageByObjectIdResponse(id=2044195, encodeId=c43b20441955f, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Thu Apr 21 18:10:39 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007484, encodeId=bf4d100e4844e, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3125569782, createdName=mingying, createdTime=Fri Aug 13 07:20:16 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453547, encodeId=10da145354e87, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1557094, encodeId=a4f5155e09494, content=<a href='/topic/show?id=154be128170' target=_blank style='color:#2F92EE;'>#癌变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71281, encryptionId=154be128170, topicName=癌变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd7914850828, createdName=axin014, createdTime=Sat Jul 17 07:10:39 CST 2021, time=2021-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000184, encodeId=d7361000184e7, content=谢谢 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f221859736, createdName=ms2658711348342440, createdTime=Fri Jul 16 22:01:25 CST 2021, time=2021-07-16, status=1, ipAttribution=)]
    2021-07-16 ms2658711348342440

    谢谢 学习了

    0

相关资讯

NEJM:急性上消化道出血内镜检查的时机

在伴有出血或死亡风险的急性上消化道出血患者中,与在消化科就诊后6-24小时内进行内窥镜检查相比,就诊后6小时内进行内窥镜检查与30天死亡率之间并无相关性。

Clin Gastroenterol H:北京大学肿瘤医院柯杨教授团队“食管癌精准防治策略研究”取得新进展

2019年9月14日,美国胃肠病学会(American Gastroenterology Association,AGA)官方学术期刊Clinical Gastroenterology & Hepatology在线发表了北京大学肿瘤医院柯杨教授团队题为“Absence of Iodine Staining Associates with Progression of Esophageal Lesi

2019 ASGE指南:内镜检查在慢性放射性直肠病出血中的作用

2019年6月,美国胃肠内镜学会(ASGE)发布了内镜检查在慢性放射性直肠病出血中的作用的指南。慢性放射性直肠病是盆腔恶性肿瘤放射治疗常见的后遗症,多种医学和内镜治疗已经被用于治疗慢性放射性直肠病出血。本文主要针对内镜检查在慢性放射性直肠病出血中的作用提出了临床问题和建议。

2018 GESA共识声明:内镜检查产碳青霉烯肠杆菌科感染控制

产碳青霉烯肠杆菌科临床感染暴发与内镜检查相关,这些与感染相关的高发病率和死亡率强调需要重新评估内镜检查后的再处理。澳大利亚胃肠病学会(GESA)组成了多学科工作小组针对内镜检查传播的产碳青霉烯肠杆菌科感染的预防和管理提出了共识声明。

2018 亚洲共识:上消化道肿瘤内镜检查诊断标准

本文是由内镜专家小组制定的关于上消化道肿瘤内镜检查诊断标准共识,目的是规范消化道肿瘤的早期检查和管理。

2018 APAGE/APSDE实践指南:服用抗栓药物患者接受急诊和择期内镜检查的管理

2018年1月,亚太地区胃肠病学协会(APAGE)联合亚太消化内镜学会(APSDE)发布了服用抗栓药物患者接受急诊和择期内镜检查的管理指南。指南主要目的是辅助临床医生管理服用抗栓药物接受急诊和择期内镜检查的患者。

拓展阅读

Lancet Digit Health:通过人工智能增强心脏 MRI 预测诊断和舒张压充盈压:医院数据的建模研究

利用人工智能结合心脏磁共振成像(cMRI)数据,成功开发了一种非侵入性的方法,用于准确预测心脏病患者的诊断和左心室舒张末期压(LVEDP),显著提升了心脏功能评估的效率和准确性。

未来ICU:人工智能如何改变危重症患者的抗菌治疗

随着医疗技术的发展,预计未来将有更多的工具和方法来指导抗菌治疗,包括利用人工智能来解释复杂的临床数据。此外,抗菌药物管理计划将继续发展,以确保抗菌药物使用的适宜性和有效性。

Radiology:基于人工智能的蛋氨酸PET与增强MRI的虚拟合成

据报道,在胶质瘤中,蛋氨酸摄取与MRI扫描上的对比增强(CE)区域之间存在相关性。图像到图像的转换模型涉及到生成对抗网络的应用,该网络可以从图像中提取特征。

Nature Medicine:AI赋能外科手术:从术前诊断到术后监测

每年全球约有3.3亿台手术正在进行中,随着手术需求的不断增加和等待名单的延长,AI在优化外科手术流程和提高手术效果方面的潜力正逐步显现。

Nat Med:赵世华等团队合作使用人工智能支持的心脏磁共振成像筛查和诊断心血管疾病

该研究开发并验证了计算机化CMR解释,用于9,719例患者的11种CVD的筛查和诊断。

2024 荷兰国家指南:局部复发直肠癌

国外肿瘤科相关专家小组(统称) · 2024-04-19

2023 ASCRS临床实践指南:直肠癌的管理(补充内容)

美国结肠和直肠外科医师学会(ASCRS,American Society of Colon and Rectal Surgeons) · 2023-08-20

结直肠癌中医临床实践指南的制定及应用策略

中国中医科学院西苑医院 · 2023-06-27